GB
Therapeutic Areas
Mainz Biomed Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ColoAlert® | Colorectal Cancer Screening | Pivotal Study |
| ColoAlert® (eAArly DETECT) | Colorectal Cancer Screening | Clinical Validation |
| PancAlert | Pancreatic Cancer Early Detection | Pre-clinical |
| Multi-Cancer Early Detection (MCED) Panel | Multi-Cancer Screening | Research |
Leadership Team at Mainz Biomed
DC
Dr. Cord Dohrmann
Chief Scientific Officer
DM
Dr. Michael T. Meehan
Chief Financial Officer
DS
Dr. Seth R. Golden
Chief Commercial Officer (North America)
PD
Prof. Dr. Peter R. Galle
Chairman of the Board of Directors
TG
Thomas G. Wiggans
Board Member
AO
Abderrahim Ouarhni
Board Member
DM
Dr. Miguel de la Guardia
Board Member
PD
Prof. Dr. Jürgen F. Riemann
Scientific/Clinical Advisor
PD
Prof. Dr. Horst Neubauer
Scientific/Clinical Advisor